Physician profile
David Rabinovici
NPI 1609890599
$3,636.59
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $820 · 2021: $1,324 · 2022: $1,039 · 2023: $48.18 · 2024: $17.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $985.95 | 2019-2022 | |
| Abbvie INC. | $962.86 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $387.72 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $349.66 | 2020-2021 | |
| Ucb, INC. | $188.77 | 2019-2020 | |
| Genzyme Corporation | $159.37 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $85.23 | 2020-2022 | |
| Sk Life Science, INC. | $79.54 | 2020-2023 | |
| Neurelis, INC. | $63.79 | 2021 | |
| Biogen, INC. | $41.73 | 2020-2021 | |
| Lundbeck LLC | $35.22 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $34.95 | 2020-2021 | |
| Lilly USA, LLC | $34.84 | 2022 | |
| Zyla Life Sciences, INC. | $31.57 | 2020 | |
| Bausch Health US, LLC | $29.46 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $28.68 | 2021 | |
| Pfizer INC. | $23.77 | 2023 | |
| Avanir Pharmaceuticals, INC. | $21.32 | 2019 | |
| Kyowa Kirin, INC. | $20.73 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.22 | 2021 | |
| Corium, LLC | $15.41 | 2022 | |
| Abbott Laboratories | $13.72 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.70 | 2019 | |
| Ge Healthcare | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rabinovici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.